Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Vaccine

• Publication date

  2014-05-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vaccine.2014.03.041PMID 24681230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.

  2012cited by this paper
• Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines.

  2011cited by this paper
• Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.

  2011cited by this paper
• Nanotechnology solutions for mucosal immunization.

  2010cited by this paper
• Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.

  2010cited by this paper
• Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.

  2010cited by this paper
• Polyoxalate nanoparticles as a biodegradable and biocompatible drug delivery vehicle.

  2010cited by this paper
• Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?

  2010cited by this paper
• Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration.

  2009cited by this paper
• Trimethyl chitosan and its applications in drug delivery

  2009cited by this paper
• Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting.

  2009cited by this paper
• Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.

  2009cited by this paper
• Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications

  2008cited by this paper
• Roundtrip Ticket for Secretory IgA: Role in Mucosal Homeostasis?1

  2007cited by this paper
• Induction of secretory immunity and memory at mucosal surfaces.

  2007cited by this paper
• Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.

  2007cited by this paper
• Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.

  2006cited by this paper
• Microparticles for intranasal immunization.

  2001cited by this paper
• Nasal vaccines.

  2001cited by this paper
• Intranasal vaccines: forthcoming challenges.

  2000cited by this paper
• Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight.

  1996cited by this paper
• The mucosal immune system: from fundamental concepts to vaccine development.

  1992cited by this paper

• An overview of the use of nanoparticles in vaccine development

  2025cites this paper
• Chitosan non-particulate vaccine delivery systems

  2024cites this paper
• Polysaccharide-based platforms for nasal delivery: design, features, and perspectives

  2023cites this paper
• Emerging vaccine nanotechnology: From defense against infection to sniping cancer

  2022cites this paper
• Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.

  2022cites this paper
• Nanotechnology approaches for global infectious diseases

  2021cites this paper
• Recent advances on chitosan as an adjuvant for vaccine delivery.

  2021cites this paper
• An Overview on Chitosan-Based Adjuvant/Vaccine Delivery Systems

  2021cites this paper
• Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery

  2021cites this paper
• Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines

  2021cites this paper
• Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers.

  2020cites this paper
• Chitosan Derivatives and Their Application in Biomedicine

  2020cites this paper
• Chitosan-Based Drug Delivery System: Applications in Fish Biotechnology

  2020cites this paper
• Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen

  2019cites this paper
• Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections

  2018cites this paper
• Intranasal delivery of nanoparticle-based vaccines.

  2017cites this paper
• Guiding principles in the design of molecular bioconjugates for vaccine applications.

  2015cites this paper
• Development of chitosan–pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies

  2015cites this paper
• Conjugating influenza a (H1N1) antigen to n‐trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration

  2015cites this paper
• Mucoadhesive Chitosan Derivatives as Novel Drug Carriers.

  2015cites this paper
• PULMONARY DELIVERY OF PNEUMOCCOCAL VACCINE USING NANOCOMPOSITE MICROPARTICLE CARRIERS VIA DRY POWDER INHALATION

  2015cites this paper
• Development of chitosan–pullulan composite nanoparticles for nasal delivery of vaccines: optimisation and cellular studies

  2015cites this paper
• Antigen-conjugated N-trimethylaminoethylmethacrylate Chitosan Nanoparticles Induce Strong Immune Responses After Nasal Administration

  2014cites this paper